NCT07108114 2026-02-23
SLV-324 Treatment of Metastatic Solid Tumors
Solve Therapeutics
Phase 1 Recruiting
Clinical Trials
9 trialsNCT07272590 2025-12-09
Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting
NCT03850574 2025-08-26
TUSCANY
Aptose Biosciences Inc.
Phase 1/2 Recruiting
NCT05448599 2023-03-15
A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2 Unknown
NCT05524194 2022-09-01
6MW3511 in Patients With Advanced Solid Tumor
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2 Unknown
NCT05001451 2022-07-20
Study of GDX012 in Patients With MRD Positive AML
GammaDelta Therapeutics Limited
Phase 1 Terminated
NCT05048160 2022-05-09
A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2 Unknown
NCT01023958 2017-11-22
Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer
Boehringer Ingelheim
Phase 2 Completed
NCT00399035 2016-12-28
HORIZON II
AstraZeneca
Phase 3 Completed